Investment Column: Overseas push is a winner for Mothercare

Britvic; GW Pharmaceuticals


Our view: Buy

Share price: 423p (+7p)

The conventional wisdom is that parents are never likely to stop spending money on their children, even in a recession.

Yesterday's final results from the children's goods retailer Mothercare underlined that argument, even if the company would claim that it is being proactive in ensuring it more than survives the downturn. A push for more internet sales and opening more stores abroad contributed to a 12.4 per cent increase in full-year pre-tax profits and, more importantly for investors, a 20.8 per cent jump in the dividend.

The future, says its chief executive Ben Gordon, is more overseas stores, especially in China, knocking down rental costs in the UK, and maintaining internet sales growth, which is up 25 per cent in the past year.

Clearly there is much to shout about and investors would be crazy not to consider the shares. Mr Gordon says the stock has outperformed the market in the past year, but we are disappointed the shares were up just 3 per cent in the past quarter, before yesterday's results. The stock trades at a discount, which is good news for those looking for a bargain, but we would also worry about the market not fully getting the story.

Maybe it is the pressure on margins as a result of sterling's weakness against the dollar (the group sources much of its stock in East Asia) that has made some investors more nervous about the stock in recent weeks.

Whatever the reason, we would argue that yesterday's numbers more than compensate for any residual concerns about the group and think that, at its current level, the share price is at an attractive entry point. Buy.

Britvic

Our view: Buy

Share price: 303p (+34.25p)

Those looking for a solid investment, a strong dividend and the potential for share price growth, look no further than Britvic, the FTSE 250-listed soft drinks company that makes Tango and Robinsons squash, and which has the licence to sell Pepsi in the UK.

At first glance, there cannot be a more compelling investment case: the group posted a better than expected 16.3 per cent increase in half-year pre-tax profits yesterday and its chief executive, Paul Moody, says there is a recovery under way in the soft drinks market. Despite a 12.7 per cent rise in the share price yesterday, the stock is still undervalued.

It is true that the shares have not performed as well as others during the recovery of recent weeks, but you cannot really argue with the facts. Mr Moody says he is comfortable with the £75m full-year profits consensus view of the analysts, arguing the better health in the sector will last.

UBS's watchers argue the shares are a buy, especially given the stock's recent lack of traction. "Year to date, Britvic has outperformed the market by 7 per cent, but underperformed the beverages sector by 9 per cent. Britvic trades on 9.9 times 2009 price- earnings, a 22 per cent discount to the sector, and offers a 12 per cent free cashflow yield," notes UBS. A solid buy then, especially with a dividend increase.

Perhaps the only fly in the ointment is that the UBS experts have a 12-month price target of just 280p. We think they will have to revise that soon, however, and would be at the front of the queue to buy the shares. Buy.

GW Pharmaceuticals

Our view: Buy

Share price: 82.75p (+3.75p)

As of yesterday, GW Pharmaceuticals joined a select band of biotech companies. The group posted its maiden profit as part of its interim results, which also confirmed the news of a few weeks ago that Sativex, its cannabis-based multiple sclerosis treatment, had passed all-important final phase drug trials. GW has submitted the data for approval in the EU, with the pharma giant Bayer licensed to market the drug.

The shares are up 122 per cent in the last three months alone and while some may be concerned that the stock might run out of steam, we would argue that it will inevitably strengthen as sales of Sativex grow, and as it meets requirements to treat other conditions, such as the pain caused by cancer. The analysts at KBC Peel Hunt agree: "We continue to see further upside in the coming months as Sativex is prepared for commercial launch and is eventually approved by the main European regulators, [we] keep our 120p price target. With an additional £10m milestone to come from Bayer for UK approval, GW's cash balance remains strong."

Hindsight is a wonderful thing, and of course investors would have been better buying the shares three months ago. We would argue, however, that they are still worth buying. Buy.

Start your day with The Independent, sign up for daily news emails
Sport
sportWWE latest including Sting vs Triple H, Brock Lesnar vs Roman Reigns and The Undertaker vs Bray Wyatt
Arts and Entertainment
Louis Theroux: By Reason of Insanity takes him behind the bars again
tvBy Reason of Insanity, TV review
Arts and Entertainment
Cassetteboy's latest video is called Emperor's New Clothes rap
videoThe political parody genius duo strike again with new video
Arts and Entertainment
tvPoldark, TV review
ebooks
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Retirement Coordinator - Financial Services

Negotiable: Recruitment Genius: To provide a prompt, friendly and efficient se...

Recruitment Genius: Annuities / Pensions Administrator

Negotiable: Recruitment Genius: You will be the first point of contact for all...

Ashdown Group: HR, Payroll & Benefits Officer - Altrincham - up to £24,000.

£18000 - £24000 per annum + benefits: Ashdown Group: HR, Payroll & Benefits Of...

Ashdown Group: Learning and Development Programme Manager

£35000 - £38000 per annum + benefits : Ashdown Group: A highly successful, int...

Day In a Page

No postcode? No vote

Floating voters

How living on a houseboat meant I didn't officially 'exist'
Louis Theroux's affable Englishman routine begins to wear thin

By Reason of Insanity

Louis Theroux's affable Englishman routine begins to wear thin
Power dressing is back – but no shoulderpads!

Power dressing is back

But banish all thoughts of Eighties shoulderpads
Spanish stone-age cave paintings 'under threat' after being re-opened to the public

Spanish stone-age cave paintings in Altamira 'under threat'

Caves were re-opened to the public
'I was the bookies’ favourite to be first to leave the Cabinet'

Vince Cable interview

'I was the bookies’ favourite to be first to leave the Cabinet'
Election 2015: How many of the Government's coalition agreement promises have been kept?

Promises, promises

But how many coalition agreement pledges have been kept?
The Gaza fisherman who built his own reef - and was shot dead there by an Israeli gunboat

The death of a Gaza fisherman

He built his own reef, and was fatally shot there by an Israeli gunboat
Saudi Arabia's airstrikes in Yemen are fuelling the Gulf's fire

Saudi airstrikes are fuelling the Gulf's fire

Arab intervention in Yemen risks entrenching Sunni-Shia divide and handing a victory to Isis, says Patrick Cockburn
Zayn Malik's departure from One Direction shows the perils of fame in the age of social media

The only direction Zayn could go

We wince at the anguish of One Direction's fans, but Malik's departure shows the perils of fame in the age of social media
Young Magician of the Year 2015: Meet the schoolgirl from Newcastle who has her heart set on being the competition's first female winner

Spells like teen spirit

A 16-year-old from Newcastle has set her heart on being the first female to win Young Magician of the Year. Jonathan Owen meets her
Jonathan Anderson: If fashion is a cycle, this young man knows just how to ride it

If fashion is a cycle, this young man knows just how to ride it

British designer Jonathan Anderson is putting his stamp on venerable house Loewe
Number plates scheme could provide a licence to offend in the land of the free

Licence to offend in the land of the free

Cash-strapped states have hit on a way of making money out of drivers that may be in collision with the First Amendment, says Rupert Cornwell
From farm to fork: Meet the Cornish fishermen, vegetable-growers and butchers causing a stir in London's top restaurants

From farm to fork in Cornwall

One man is bringing together Cornwall's most accomplished growers, fishermen and butchers with London's best chefs to put the finest, freshest produce on the plates of some of the country’s best restaurants
Robert Parker interview: The world's top wine critic on tasting 10,000 bottles a year, absurd drinking notes and New World wannabes

Robert Parker interview

The world's top wine critic on tasting 10,000 bottles a year, absurd drinking notes and New World wannabes
Don't believe the stereotype - or should you?

Don't believe the stereotype - or should you?

We exaggerate regional traits and turn them into jokes - and those on the receiving end are in on it too, says DJ Taylor